Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Contineum Therapeutics in the offering, and Sidley Austin represented the underwriters. Contineum Therapeutics, a clinical stage biopharmaceutical company,...
You must be a Standard 1 Year member to access this content.
Sidley Austin represented Pyxis Oncology, Inc. on the deal. Pyxis Oncology, Inc. (Nasdaq: “PYXS”), a clinical stage company, announced that it agreed to sell 8,849,371 shares of...
You must be a Standard 1 Year member to access this content.
Sidley Austin represented Praxis Precision Medicines, Inc. in the transaction, and Ropes & Gray advised Tenacia. Praxis Precision Medicines, Inc. (NASDAQ: PRAX) announced it has entered...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Klaviyo, and Sidley Austin advised the underwriters on the offering. Klaviyo, Inc. announced the pricing of its initial public offering of 19,200,000 shares of...
You must be a Standard 1 Year member to access this content.
Sidley Austin advised IO Biotech, and Latham & Watkins advised the placement agents. IO Biotech, Inc. (Nasdaq: IOBT) announced that it has entered into a definitive...
You must be a Standard 1 Year member to access this content.
Sidley represented Northpond Ventures in its investment. Telesis Bio Inc. (NASDAQ: TBIO) announced it has signed a securities purchase agreement with a syndicate of healthcare-focused institutional...
You must be a Standard 1 Year member to access this content.
Sidley represented Atia Vision Inc. on the deal. Atia Vision Inc. announced its Series E financing led by Cormorant Asset Management with participation by The Capital Partnership,...
You must be a Standard 1 Year member to access this content.
Sidley advised Sound Agriculture on the deal while WilmerHale represented Northpond Ventures. Sound Agriculture, a leading agtech company that is improving farming and food, announced a US$75...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Tyra Biosciences in the offering while Sidley advised the underwriters. Tyra Biosciences, Inc. has announced the pricing of its upsized initial public offering of...
You must be a Standard 1 Year member to access this content.
Sidley Austin advised the underwriters on the deal, while Choate and Latham & Watkins assisted Immuneering Corporation. Immuneering Corporation (Nasdaq: IMRX), a biopharmaceutical company advancing a...
You must be a Standard 1 Year member to access this content.
Sidley Austin LLP advised NuVera Medical on the deal. NuVera Medical, Inc., a medical technology company, announced its acquisition by Ethicon, Inc., a wholly-owned subsidiary of...
You must be a Standard 1 Year member to access this content.
Sidley Austin LLP advised NuVera Medical on the deal. NuVera Medical, Inc., a medical technology company, announced its acquisition by Ethicon, Inc., a wholly-owned subsidiary of...
You must be a Standard 1 Year member to access this content.
